As of 2026-09-15, the Relative Valuation of Oric Pharmaceuticals Inc (ORIC) is (36.54) USD. This relative valuation is based on P/E multiples. With the latest stock price at 12.65 USD, the upside of Oric Pharmaceuticals Inc based on Relative Valuation is -388.8%.
The range of the Relative Valuation is (32.13) - (40.54) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 23.6x - 29.9x | 26.8x |
| Forward P/E multiples | 23.7x - 30.6x | 27.2x |
| Fair Price | (32.13) - (40.54) | (36.54) |
| Upside | -354.0% - -420.5% | -388.8% |
| Date | P/E |
| 2026-09-14 | -9.18 |
| 2026-09-11 | -8.88 |
| 2026-09-10 | -8.90 |
| 2026-09-09 | -9.22 |
| 2026-09-08 | -9.31 |
| 2026-09-04 | -9.49 |
| 2026-09-03 | -9.40 |
| 2026-09-02 | -9.68 |
| 2026-09-01 | -9.51 |
| 2026-08-31 | -9.58 |
| 2026-08-28 | -9.77 |
| 2026-08-27 | -10.13 |
| 2026-08-26 | -10.26 |
| 2026-08-25 | -10.20 |
| 2026-08-24 | -9.93 |
| 2026-08-21 | -10.47 |
| 2026-08-20 | -10.24 |
| 2026-08-19 | -10.81 |
| 2026-08-18 | -10.27 |
| 2026-08-17 | -9.87 |
| 2026-08-14 | -10.23 |
| 2026-08-13 | -10.12 |
| 2026-08-12 | -10.14 |
| 2026-08-11 | -10.13 |
| 2026-08-10 | -10.05 |
| 2026-08-07 | -9.96 |
| 2026-08-06 | -9.54 |
| 2026-08-05 | -9.54 |
| 2026-08-04 | -9.94 |
| 2026-08-03 | -7.82 |
| 2026-07-31 | -8.17 |
| 2026-07-30 | -8.59 |
| 2026-07-29 | -8.32 |
| 2026-07-28 | -8.78 |
| 2026-07-27 | -8.87 |
| 2026-07-24 | -8.92 |
| 2026-07-23 | -8.03 |
| 2026-07-22 | -7.93 |
| 2026-07-21 | -7.99 |
| 2026-07-20 | -7.69 |
| 2026-07-17 | -7.91 |
| 2026-07-16 | -7.91 |
| 2026-07-15 | -8.22 |
| 2026-07-14 | -7.78 |
| 2026-07-13 | -7.72 |
| 2026-07-10 | -8.00 |
| 2026-07-09 | -8.07 |
| 2026-07-08 | -8.04 |
| 2026-07-07 | -8.02 |
| 2026-07-06 | -8.05 |